In January, Cordy lab received funding of $10,000 by the Center for Redox Biology and Medicine for the project entitled “Characterizing Off-Target Oxidative Damage in Human Red Blood Cells During High-Dose Vitamin C Treatment Using an In Vitro Model of the Malaria Bystander Effect.”